CN104721407A - Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis - Google Patents

Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis Download PDF

Info

Publication number
CN104721407A
CN104721407A CN201510151377.1A CN201510151377A CN104721407A CN 104721407 A CN104721407 A CN 104721407A CN 201510151377 A CN201510151377 A CN 201510151377A CN 104721407 A CN104721407 A CN 104721407A
Authority
CN
China
Prior art keywords
herba
parts
chinese medicine
cholecystitis
medicine composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510151377.1A
Other languages
Chinese (zh)
Inventor
宁宁
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510151377.1A priority Critical patent/CN104721407A/en
Publication of CN104721407A publication Critical patent/CN104721407A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention relates to a traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis. The traditional Chinese medicine composition is prepared from Chinese eupatorium, chrysasplenium nudicaule, fleshfingered citron flower, latifolious rush rhizome, saxifraga unguiculata, horseweed herb, clinopodium polycephalum, tibetan saxifrage, ellpticleaf spurgentian root, calamint and desmodium styracifolium. The traditional Chinese medicine composition disclosed by the invention can be clinically used for treating liver-depression and qi-stagnation type cholecystitis.

Description

A kind of Chinese medicine composition for the treatment of caused by hepatic stagnation qi stagnation cholecystitis
Technical field
The invention belongs to technical field of Chinese medicines, particularly relate to a kind of Chinese medicine composition for the treatment of caused by hepatic stagnation qi stagnation cholecystitis.
Background technology
Chronic cholecystitis is common clinical, frequently-occurring disease, refers to the chronic inflammation pathological changes of gallbladder, how repeatedly to be delayed caused by outbreak by chronic infection, calculus, chemical stimulation and acute cholecystitis, has touching, the easy feature repeatedly of patient's condition.In recent years, because work rhythm is accelerated, living standard improves constantly, and the picked-up of fats, high protein diet increases, and primary disease sickness rate is in rising trend.Long-term practice through inventor draws, the strongly fragrant qi stagnation cholecystitis of Chinese medicine treating the liver has better effect, obtains good effect.
Summary of the invention
The object of the present invention is to provide that a kind of therapeutic effect is good, effective percentage is high, Chinese medicine composition to the treatment caused by hepatic stagnation qi stagnation cholecystitis of human non-toxic's side effect.
The object of the present invention is achieved like this, according to Chinese medical theory, utilize the property of medicine of Chinese medicine uniqueness, adopt Herba Serissae, Chrysasplenium nudicaule, Flos Citri Sarcodactylis, Juncus amplifolius A. Camus, pawl Herba Saxifragae, Conyza canadensis (L.) Cronq., Herba Clinopodii, Herba Saxifragae przewalskii Radix haleniae ellipticae, Herba Clinopodii Polycephali, Herba Desmodii Styracifolii according to certain compatibility requirement, through being processed into.
Prepare Chinese medicine composition of the present invention to be made up of following raw material medicaments: Herba Serissae 30-50 part, Chrysasplenium nudicaule 20-40 part, Flos Citri Sarcodactylis 20-40 part, Juncus amplifolius A. Camus 20-40 part, pawl Herba Saxifragae 15-25 part, Conyza canadensis (L.) Cronq. 15-25 part, Herba Clinopodii 15-25 part, Herba Saxifragae przewalskii 15-25 part, Radix haleniae ellipticae 9-15 part, Herba Clinopodii Polycephali 9-15 part, Herba Desmodii Styracifolii 9-15 part.
Optimum weight part of traditional Chinese medicinal composition raw materials of the present invention is: Herba Serissae 40 parts, Chrysasplenium nudicaule 30 parts, Flos Citri Sarcodactylis 30 parts, Juncus amplifolius A. Camus 30 parts, pawl Herba Saxifragae 20 parts, Conyza canadensis (L.) Cronq. 20 parts, Herba Clinopodii 20 parts, Herba Saxifragae przewalskii 20 parts, Radix haleniae ellipticae 12 parts, Herba Clinopodii Polycephali 12 parts, Herba Desmodii Styracifolii 12 parts.
The pharmacological action of Chinese medicine of the present invention is as follows:
Herba Serissae: bitter, pungent is flat.Dispersing the stagnated live-QI to relieve the stagnation of QI, opens breast profit diaphragm, regulating menstruation promoting the circulation of blood, reducing swelling and alleviating pain.Cure mainly flu, chest and hypochondrium, stomachache, abdominal distention, puerperal edema, postnatal blood stasis pain, menoxenia, rheumatic arthritis, traumatic injury, snakebite, ecthyma.
Chrysasplenium nudicaule: bitter, cold.Removing damp-heat, depressed liver-energy dispersing and function of gallbladder promoting.Cure mainly jaundice, hypochondriac pain , mass in the abdomen, cholecystitis, cholelithiasis.
Flos Citri Sarcodactylis: micro-hardship, tepor.Depressed liver-energy dispersing and QI regulating, the fast diaphragm of stomach function regulating.Cure mainly stomachache due to hyperactive liver-QI attacking the stomach, inappetence.
Juncus amplifolius A. Camus: bitter, pungent is flat.Regulating QI to relieve pain, regulating menstruation and activating blood.Cure mainly stagnation of QI due to depression of the liver, pain in chest and hypochondrium, menoxenia, metrorrhagia leukorrhagia.
Pawl Herba Saxifragae: bitter, cold.Heat-clearing and toxic substances removing.Cure mainly cholecystitis, hepatitis, heating, carbuncle poison.
Conyza canadensis (L.) Cronq.: micro-hardship, pungent, cool.Clearing away heat-damp and promoting diuresis, removing toxic substances and promoting subsidence of swelling.Cure mainly dysentery, enteritis, hepatitis, cholecystitis, otitis media, conjunctivitis, traumatic injury, rheumatic ostalgia, furuncle swells and ache, traumatic hemorrhage, eczema, psoriasis.
Herba Clinopodii: pungent is bitter, cool.Heat-clearing and toxic substances removing, removing heat from blood and promoting blood circulation.Cure mainly anemopyretic cold, cough, conjunctival congestion and swelling pain, laryngopharynx swelling and pain, diphtheria, stomachache dysentery, spits blood, spitting of blood, hematuria, metrorrhagia, traumatic hemorrhage, hepatitis, cholecystitis, mumps, and stomachache, arthralgia, skin infection swells and ache, venom, eczema, hemorrhoid, treating swelling and pain by traumatic injury.
Herba Saxifragae przewalskii: micro-bitter, acrid, cold.The heat of liver heat removing gallbladder, stomach invigorating.Cure mainly hepatitis, cholecystitis, influenza is had a fever, dyspepsia.
Radix haleniae ellipticae: bitter, cold.Heat-clearing and toxic substances removing, depressed liver-energy dispersing and function of gallbladder promoting, dispelling wind and relieving.Cure mainly acute hepatitis, chronic hepatitis, cholecystitis, gastroenteritis, influenza, throat pain, toothache, vasculitis, trauma infection contamination generates heat, and heatstroke is suffered from abdominal pain, traumatic hemorrhage.
Herba Clinopodii Polycephali: pungent, bitter, cool.Wind and heat dispersing, removing toxic substances and promoting subsidence of swelling, hemostasis.Cure mainly cold, fever, heatstroke, laryngopharynx swelling and pain, diphtheria, acute cholecystitis, hepatitis, enteritis, dysentery, parotitis, mastitis, furuncle swelling toxin, allergic dermatitis, acute conjunctivitis, hematuria, metrorrhagia, gingival hemorrhage, traumatic hemorrhage.
Herba Desmodii Styracifolii: sweet, light, cool.Clearing away heat-damp and promoting diuresis, Tonglin Paishi.Cure mainly urinary system infection, urinary system calculus, oedema due to nephritis, cholecystitis, cholelithiasis, icterohepatitis, infantile malnutrition, carbuncle.
Caused by hepatic stagnation qi stagnation cholecystitis belongs to the category such as the traditional Chinese medical science " hypochondriac pain ", " feeling of fullness ".Its cause of disease is many is become estranged by eating and drinking without temperance, the unsuccessful liver network that causes of feelings will.Its disease is at gallbladder, but relevant with liver and taste.Herba Serissae dispersing the stagnated live-QI to relieve the stagnation of QI in the present invention is monarch drug; Chrysasplenium nudicaule depressed liver-energy dispersing and function of gallbladder promoting, Flos Citri Sarcodactylis depressed liver-energy dispersing and QI regulating, Juncus amplifolius A. Camus regulating QI to relieve pain are ministerial drug, pawl Herba Saxifragae heat-clearing and toxic substances removing, Conyza canadensis (L.) Cronq. removing toxic substances and promoting subsidence of swelling, Herba Clinopodii removing heat from blood and promoting blood circulation, the heat of Herba Saxifragae przewalskii liver heat removing gallbladder, Radix haleniae ellipticae depressed liver-energy dispersing and function of gallbladder promoting, Herba Clinopodii Polycephali removing toxic substances and promoting subsidence of swelling, Herba Desmodii Styracifolii clearing away heat-damp and promoting diuresis.Find through clinical practice, have unique curative effect to caused by hepatic stagnation qi stagnation cholecystitis, effect of dispersing the stagnated live-QI to relieve the stagnation of QI, heat-clearing and toxic substances removing, regulating QI to relieve pain played altogether by all medicines, reaches the object for the treatment of caused by hepatic stagnation qi stagnation cholecystitis.
Chinese medicine composition of the present invention was in 2010 to 2012 the routine patients of clinical observation caused by hepatic stagnation qi stagnation cholecystitis 100, and clinical report is as follows:
1, physical data
In 100 routine patients, in age 17-63 year, the course of disease is many at 5 months to 7 years, 44 years old mean age.
2, diagnostic criteria
" Chinese medical disease Standardization of diagnosis and curative effect " that 2.1 diagnosis basis State Administration of Traditional Chinese Medicines issue: 1. persistence upper right abdomen dull pain or sense of discomfort, or Ban You omoplate district pain; 2. the indigestion symptoms such as nauseating, belch, acid regurgitation, abdominal distention and scorching hot are had, the postemphasis of feed greasy food; 3. the course of disease is long, and the state of an illness has acute attack and alleviates feature alternately; 4. gallbladder area is carved with mild tenderness and is kowtowed pain; 5. in bile, mucus increases, and leukocyte is in heaps, positive bacterial culture; 6. the visible cholelithiasis of ultrasound diagnosis, thickening of capsule wall of gallbladder, gallbladder reduces or is out of shape; 7. the visible cholelithiasis of cholecystography, gallbladder reduces or is out of shape, and gallbladder contraction function is bad, or gallbladder development is thin.
Clinical symptoms: depressed emotion or susceptible to lose temper due to restlessness, side of body rib alters pain, and draw and upper abdomen or shoulder back, oppression sensation over the epigastrium, sighing frequently, belch is frequent, pale tongue with white fur or greasy in vain, stringy and tense pulse.
2.2 exclusion standards: 1. the age is below 17 years old or more than 63 years old person; 2. acute gangrenous cholecystitis, the suppurative cholecystitis of acute obstruction, perforation of gallbladder peritonitis person; 3. gestation or women breast-feeding their children, be associated with severe primary disease, the psychotics such as cardiovascular, liver, kidney and hemopoietic system.
3, Therapeutic Method:
3.1 prescriptions: Herba Serissae 40g, Chrysasplenium nudicaule 30g, Flos Citri Sarcodactylis 30g, Juncus amplifolius A. Camus 30g, pawl Herba Saxifragae 20g, Conyza canadensis (L.) Cronq. 20g, Herba Clinopodii 20g, Herba Saxifragae przewalskii 20g, Radix haleniae ellipticae 12g, Herba Clinopodii Polycephali 12g, Herba Desmodii Styracifolii 12g.
3.2 methods of preparation and use: said medicine routinely technique makes decoction, every day 1 dose, every day 2 times 15 days was 1 course for the treatment of.
4, therapeutic outcome:
4.1 specify with reference to " Chinese medicine Clinical Researches of New Drugs guideline ":
Cure: the primary and secondary syndrome of this syndrome disappears, ultrasound diagnosis gallbladder wall and contractile function recover normal, and gallbladder district pain disappears, and diet, digestion recover normal.Drug withdrawal 3 months is unchanged, follows up a case by regular visits to half a year more than without recurrence;
Take a turn for the better: the improvement of this syndrome primary and secondary syndrome accounts for more than half, and ultrasound diagnosis gallbladder wall and contractile function have clear improvement, and gallbladder district tenderness is clearly better, diet, digestion are clearly better;
Invalid: through treatment symptom without alleviation, ultrasound diagnosis gallbladder wall and contractile function are without significant change, and every symptom is not improved.
4.2 results: in 100 routine patients, cure 64 examples (64%), 33 examples that take a turn for the better (33%), and invalid 3 examples (3%), total effective rate is 97%.
5, model case
5.1 Zhao, man, 32 years old.Suffer from cholecystitis 2 years.Time medical, hypochondriac pain is indistinctly walked to alter indefinite, and connect and shoulder back also pain, then hypochondriac pain is fixing does not at nightfall move, and xerostomia is bitter, pale tongue with white fur, stringy and thready pulse.Ultrasound diagnosis, cyst wall thickens, and volume increases, and gallbladder wall is rough and coarse.Be diagnosed as caused by hepatic stagnation qi stagnation cholecystitis.Take medicine of the present invention, treat 2 courses for the treatment of, symptom obviously alleviates, and through B ultrasonic check, gallbladder clear-cut, smooth, size shape is normal, continues to take 2 courses for the treatment of, recovery from illness, follows up a case by regular visits to without recurrence after half a year.
5.2 Zhangs, female, 38 years old.Suffer from cholecystitis 4 years, immediate cause house hold affairs, mind is irritated, and side of body rib is walked to alter pain, then fixes pain at nightfall, and to the radiation of shoulder back during pain, delayed menstrual cycle, inappetence, appetite reduces, pale tongue with white fur, stringy and tense pulse, and above symptom increases and decreases with feelings will quality.Be diagnosed as caused by hepatic stagnation qi stagnation cholecystitis.Take medicine of the present invention, every day 1 dose, after 2 courses for the treatment of, symptom is clearly better, and continues to take 2 courses for the treatment of, and through B ultrasonic check, gallbladder clear-cut, smooth, size and form is normal, and recovery from illness is followed up a case by regular visits to after half a year without recurrence.
5.3 Dong, man, 53 years old.Because upper right abdominal distention and pain once arrived certain hospital therapy, be diagnosed as acute cholecystitis, give intravenous drip levofloxacin, remission.There is right Upper abdominal pain when not relaxing in the greasy or feelings will of after this often taking food, and to lower back radiation, companion feels sick.Because there is upper right abdomen dull pain, abdominal distention, singultus after feed Carnis Sus domestica, vomiting.The light tenderness of upper right abdomen, do not touch gallbladder, Fei Shi does not levy (+).Ultrasound diagnosis: gallbladder wall hair, thicken, visit and 3.0mm × 5.0mm stone-echo in capsule.Be diagnosed as caused by hepatic stagnation qi stagnation cholecystitis, cholelithiasis.Take medicine of the present invention, after 2 courses for the treatment of, symptom obviously alleviates, and continues to take 3 courses for the treatment of, and symptom and sign disappears, and B ultrasonic is checked: gallbladder volume is normal, and wall is smooth, does not visit and stone-echo in capsule, and recovery from illness is followed up a case by regular visits to after half a year without recurrence.
Detailed description of the invention
Below in conjunction with embodiment, the present invention is further illustrated, and this embodiment following does not only limit the present invention for illustration of the present invention.
Embodiment 1, treating a Chinese medicine composition for caused by hepatic stagnation qi stagnation cholecystitis, is be made up of Herba Serissae 30g, Chrysasplenium nudicaule 20g, Flos Citri Sarcodactylis 20g, Juncus amplifolius A. Camus 20g, pawl Herba Saxifragae 15g, Conyza canadensis (L.) Cronq. 15g, Herba Clinopodii 15g, Herba Saxifragae przewalskii 15g, Radix haleniae ellipticae 9g, Herba Clinopodii Polycephali 9g, Herba Desmodii Styracifolii 9g.
Embodiment 2, treating a Chinese medicine composition for caused by hepatic stagnation qi stagnation cholecystitis, is be made up of Herba Serissae 40g, Chrysasplenium nudicaule 30g, Flos Citri Sarcodactylis 30g, Juncus amplifolius A. Camus 30g, pawl Herba Saxifragae 20g, Conyza canadensis (L.) Cronq. 20g, Herba Clinopodii 20g, Herba Saxifragae przewalskii 20g, Radix haleniae ellipticae 12g, Herba Clinopodii Polycephali 12g, Herba Desmodii Styracifolii 12g.
Embodiment 3, treating a Chinese medicine composition for caused by hepatic stagnation qi stagnation cholecystitis, is be made up of Herba Serissae 50g, Chrysasplenium nudicaule 40g, Flos Citri Sarcodactylis 40g, Juncus amplifolius A. Camus 40g, pawl Herba Saxifragae 25g, Conyza canadensis (L.) Cronq. 25g, Herba Clinopodii 25g, Herba Saxifragae przewalskii 25g, Radix haleniae ellipticae 15g, Herba Clinopodii Polycephali 15g, Herba Desmodii Styracifolii 15g.

Claims (2)

1. treat a Chinese medicine composition for caused by hepatic stagnation qi stagnation cholecystitis, it is characterized in that it is made up of following raw material medicaments: Herba Serissae 30-50 part, Chrysasplenium nudicaule 20-40 part, Flos Citri Sarcodactylis 20-40 part, Juncus amplifolius A. Camus 20-40 part, pawl Herba Saxifragae 15-25 part, Conyza canadensis (L.) Cronq. 15-25 part, Herba Clinopodii 15-25 part, Herba Saxifragae przewalskii 15-25 part, Radix haleniae ellipticae 9-15 part, Herba Clinopodii Polycephali 9-15 part, Herba Desmodii Styracifolii 9-15 part.
2. Chinese medicine composition according to claim 1, is characterized in that it is made up of following raw material medicaments: Herba Serissae 40 parts, Chrysasplenium nudicaule 30 parts, Flos Citri Sarcodactylis 30 parts, Juncus amplifolius A. Camus 30 parts, pawl Herba Saxifragae 20 parts, Conyza canadensis (L.) Cronq. 20 parts, Herba Clinopodii 20 parts, Herba Saxifragae przewalskii 20 parts, Radix haleniae ellipticae 12 parts, Herba Clinopodii Polycephali 12 parts, Herba Desmodii Styracifolii 12 parts.
CN201510151377.1A 2015-04-01 2015-04-01 Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis Pending CN104721407A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510151377.1A CN104721407A (en) 2015-04-01 2015-04-01 Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510151377.1A CN104721407A (en) 2015-04-01 2015-04-01 Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis

Publications (1)

Publication Number Publication Date
CN104721407A true CN104721407A (en) 2015-06-24

Family

ID=53446203

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510151377.1A Pending CN104721407A (en) 2015-04-01 2015-04-01 Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis

Country Status (1)

Country Link
CN (1) CN104721407A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147812A (en) * 2015-10-26 2015-12-16 钱燕燕 Chinese medicine for treating qi stagnation and blood stasis chronic cholecystitis and preparation method
CN105213655A (en) * 2015-11-16 2016-01-06 张风香 A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101698066A (en) * 2009-11-05 2010-04-28 广西万通制药有限公司 Chinese medicine preparation capable of diminishing inflammation, relieving pains, resisting bacteria, expelling stone and benefiting gallbladder, and preparation method and applications thereof
CN103520531A (en) * 2013-09-23 2014-01-22 刘兰霞 Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101698066A (en) * 2009-11-05 2010-04-28 广西万通制药有限公司 Chinese medicine preparation capable of diminishing inflammation, relieving pains, resisting bacteria, expelling stone and benefiting gallbladder, and preparation method and applications thereof
CN103520531A (en) * 2013-09-23 2014-01-22 刘兰霞 Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
丁彩霞,等。: ""慢性胆囊炎的中医治疗概述"", 《辽宁中医药大学学报》 *

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105147812A (en) * 2015-10-26 2015-12-16 钱燕燕 Chinese medicine for treating qi stagnation and blood stasis chronic cholecystitis and preparation method
CN105213655A (en) * 2015-11-16 2016-01-06 张风香 A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis

Similar Documents

Publication Publication Date Title
CN102872359B (en) Traditional Chinese medicine composition for treating chronic cholecystitis
CN103520531B (en) Traditional Chinese medicinal composition for treating liver depression and qi stagnation type cholecystitis
CN104721407A (en) Traditional Chinese medicine composition for treating liver-depression and qi-stagnation type cholecystitis
CN102872362B (en) Traditional Chinese medicine for treating chronic cholecystitis
CN103495061B (en) Traditional Chinese medicine composition for treating cholecystitis caused by stagnation of liver qi and phlegm and blood stasis
CN103479884B (en) Traditional Chinese medicine composition for treating cholecystitis caused by liver-kidney yin deficiency
CN103083619B (en) Traditional Chinese medicine composition for treating biliary tract ascariasis
CN102688400B (en) Succus bambusae traditional Chinese medicine oral liquid for treating cough and preparation method for oral liquid
CN102091279A (en) Traditional Chinese medicine composition for treating duodenal ulcer
CN103520637B (en) Traditional Chinese medicine composition for treatment of dampness and heat accumulation type cholecystitis
CN104721571A (en) Traditional Chinese medicine composition for treating liver-depression stomach-heat type mammary abscess
CN104027631A (en) Traditional Chinese medicine preparation for treating liver depression and phlegm stagnation type cholecystitis
CN103536851A (en) Traditional Chinese medicine composition for treating alcoholic fatty liver
CN103830481A (en) Medicine for treating recurrent respiratory tract infection of children
CN103877382A (en) Traditional Chinese medicine preparation for treating hemorrhoids with blood stool
CN102973899B (en) Traditional Chinese medicine composition for treating cholelithiasis
CN101019966B (en) Tonic wine with brain nourishing, Yang strengthening and other function and its prepn process
CN106266461A (en) A kind of Chinese medicine composition assisting treatment liver gallbladder damp-heat type acute cholecystitis
CN105213655A (en) A kind of Chinese medicine composition of adjuvant treatment of acute cholecystitis
CN104721416A (en) TCM (traditional Chinese medicine) composition for treating milk obstruction
CN104922525A (en) Traditional Chinese medicine composition for treating pulmonary abscess
CN103251841A (en) Chinese medicinal composition for treating qi-depression phlegm-heat imagined bolus in throat
CN104027520A (en) Traditional Chinese medicine for treating liver-qi stagnation type cholecystitis
CN103463569A (en) Traditional Chinese medicine preparation for treating duodenal ulcer
CN104474278A (en) Traditional Chinese medicine composition for treating liver and kidney yin-deficiency type cholecystitis

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C53 Correction of patent of invention or patent application
CB02 Change of applicant information

Address after: 250014 No. 1 Yao Jia Zhuang, Lixia District, Shandong, Ji'nan

Applicant after: Ning Ning

Address before: 250014 Shandong city of Qingdao Province North Dengzhou Road No. 38

Applicant before: Ning Ning

COR Change of bibliographic data

Free format text: CORRECT: ADDRESS; FROM: 250014 QINGDAO, SHANDONG PROVINCE TO: 250014 JINAN, SHANDONG PROVINCE

WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20150624

WD01 Invention patent application deemed withdrawn after publication